You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
映恩生物-B(09606.HK)股價異常波動 新聞文章所載資料並不構成內幕消息
格隆匯 06-10 19:27

格隆匯6月10日丨映恩生物-B(09606.HK)公告,映恩生物董事會得悉最近公司股份於2025年6月9日及2025年6月10日於聯交所的成交價格及成交量的波動。董事會亦得悉,公司於2025年6月5日在其網站上發佈一篇新聞文章,內容涉及公司於2025年美國臨牀腫瘤學會(ASCO)年會上以口頭報告形式公佈的ADC候選藥物的初步數據(https://www.dualitybiologics.com/news/590.html)。

經作出一切有關公司於相關情況下的合理查詢後,董事會確認,(i)就上市規則第13.09(2)條或香港法例第571章證券及期貨條例第XIVA部項下的內幕消息條文而言,新聞文章所載資料並不構成內幕消息;(ii)其並不知悉有關導致該等股份的成交價格及成交量波動的任何原因,或任何必須公佈以避免公司證券出現虛假市場的資料,或任何須予披露的內幕消息;及(iii)公司運作一切正常。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account